Published in PLoS Biol on September 23, 2008
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol (2011) 3.02
Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet (2011) 2.73
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J Clin Invest (2012) 2.62
Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metab (2010) 2.58
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev (2015) 2.51
Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J Lipid Res (2011) 1.94
Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes (2011) 1.91
Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol (2011) 1.89
Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation. Cell (2011) 1.76
Alternative Perspectives on Aging in Caenorhabditis elegans: Reactive Oxygen Species or Hyperfunction? Antioxid Redox Signal (2012) 1.53
Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne) (2013) 1.47
Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss. PLoS One (2010) 1.38
Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition. J Clin Invest (2012) 1.35
Functional differences in visceral and subcutaneous fat pads originate from differences in the adipose stem cell. PLoS One (2012) 1.25
Hypothalamic AgRP-neurons control peripheral substrate utilization and nutrient partitioning. EMBO J (2012) 1.17
Brown fat fuel utilization and thermogenesis. Trends Endocrinol Metab (2014) 1.12
Brown and white adipose tissues: intrinsic differences in gene expression and response to cold exposure in mice. Am J Physiol Endocrinol Metab (2014) 1.12
The genetics of obesity. Curr Diab Rep (2010) 1.11
Genetics and epigenetics of aging and longevity. Cell Cycle (2014) 1.07
Central ceramide-induced hypothalamic lipotoxicity and ER stress regulate energy balance. Cell Rep (2014) 1.06
Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS One (2011) 1.00
Role of nuclear receptor corepressor RIP140 in metabolic syndrome. Biochim Biophys Acta (2010) 0.96
Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity. Int J Obes (Lond) (2010) 0.96
The transcription factor paired-related homeobox 1 (Prrx1) inhibits adipogenesis by activating transforming growth factor-β (TGFβ) signaling. J Biol Chem (2012) 0.96
The fat controller: adipocyte development. PLoS Biol (2012) 0.94
Epicardial fat gene expression after aerobic exercise training in pigs with coronary atherosclerosis: relationship to visceral and subcutaneous fat. J Appl Physiol (1985) (2010) 0.94
Mitochondrial dysfunction: a basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities. Mediators Inflamm (2013) 0.93
Fat accumulation in Caenorhabditis elegans triggered by the electrophilic lipid peroxidation product 4-hydroxynonenal (4-HNE). Aging (Albany NY) (2008) 0.93
Polycystic ovary syndrome in the pediatric population. Metab Syndr Relat Disord (2010) 0.93
Visceral adiposity index (VAI) is predictive of an altered adipokine profile in patients with type 2 diabetes. PLoS One (2014) 0.91
Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women. J Clin Endocrinol Metab (2016) 0.90
Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat. Psychopharmacology (Berl) (2011) 0.89
Does Metabolically Healthy Obesity Exist? Nutrients (2016) 0.86
Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model. Dis Model Mech (2012) 0.86
Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders. J Diabetes Res (2015) 0.86
Contrasting cellularity and fatty acid composition in fat depots from Alentejana and Barrosã bovine breeds fed high and low forage diets. Int J Biol Sci (2012) 0.85
Hypothalamic ceramide levels regulated by CPT1C mediate the orexigenic effect of ghrelin. Diabetes (2013) 0.85
A new role for lipocalin prostaglandin d synthase in the regulation of brown adipose tissue substrate utilization. Diabetes (2012) 0.83
Lipocalin prostaglandin D synthase and PPARγ2 coordinate to regulate carbohydrate and lipid metabolism in vivo. PLoS One (2012) 0.82
Higher plasma lipopolysaccharide concentrations are associated with less favorable phenotype in overweight/obese men. Eur J Nutr (2014) 0.81
De novo lipogenesis in metabolic homeostasis: More friend than foe? Mol Metab (2015) 0.81
Fyn deficiency promotes a preferential increase in subcutaneous adipose tissue mass and decreased visceral adipose tissue inflammation. Diabetes (2013) 0.80
Obesity and psychotic disorders: uncovering common mechanisms through metabolomics. Dis Model Mech (2012) 0.79
Impact of Doxorubicin Treatment on the Physiological Functions of White Adipose Tissue. PLoS One (2016) 0.79
Integrating post-genomic approaches as a strategy to advance our understanding of health and disease. Genome Med (2009) 0.79
Granulocyte/Macrophage Colony-stimulating Factor-dependent Dendritic Cells Restrain Lean Adipose Tissue Expansion. J Biol Chem (2015) 0.79
Abdominal fat distribution and its relationship to brain changes: the differential effects of age on cerebellar structure and function: a cross-sectional, exploratory study. BMJ Open (2013) 0.79
Tissue-specific effects of bariatric surgery including mitochondrial function. J Obes (2011) 0.79
"Mens sana in corpore sano": exercise and hypothalamic ER stress. PLoS Biol (2010) 0.78
Microglia activation due to obesity programs metabolic failure leading to type two diabetes. Nutr Diabetes (2017) 0.78
Pharmacological treatment of obesity in patients with polycystic ovary syndrome. J Obes (2010) 0.77
Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role? Semin Reprod Med (2014) 0.77
Transglutaminase 2--a novel inhibitor of adipogenesis. Cell Death Dis (2015) 0.77
Differences in the Osteogenic Differentiation Capacity of Omental Adipose-Derived Stem Cells in Obese Patients With and Without Metabolic Syndrome. Endocrinology (2015) 0.76
Carnosic Acid Inhibits Lipid Accumulation in 3T3-L1 Adipocytes Through Attenuation of Fatty Acid Desaturation. J Cancer Prev (2015) 0.75
Polymerase I and transcript release factor (PTRF) regulates adipocyte differentiation and determines adipose tissue expandability. FASEB J (2014) 0.75
Downregulation of de Novo Fatty Acid Synthesis in Subcutaneous Adipose Tissue of Moderately Obese Women. Int J Mol Sci (2015) 0.75
Photoperiod induced obesity in the Brandt's vole (Lasiopodomys brandtii): a model of 'healthy obesity'? Dis Model Mech (2016) 0.75
The 6th Annual World Congress on the insulin resistance syndrome. Diabetes Care (2009) 0.75
CoA protects against the deleterious effects of caloric overload in Drosophila. J Lipid Res (2016) 0.75
The Immune System in Obesity: Developing Paradigms Amidst Inconvenient Truths. Curr Diab Rep (2017) 0.75
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 17.49
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med (2006) 10.97
Dynamics of fat cell turnover in humans. Nature (2008) 9.80
Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest (2007) 8.71
Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature (2000) 5.86
Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab (2008) 5.07
Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev (1998) 4.86
Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A (2006) 4.81
The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr (2006) 4.35
PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J (1996) 4.11
Splanchnic lipolysis in human obesity. J Clin Invest (2004) 3.94
How obesity causes diabetes: not a tall tale. Science (2005) 3.89
Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab (2006) 3.72
The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab (2005) 3.21
PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet (2007) 2.91
Are there persons who are obese, but metabolically healthy? Metabolism (2001) 2.80
Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr (2003) 2.70
Adipose tissue as a buffer for daily lipid flux. Diabetologia (2002) 2.65
PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am J Physiol Endocrinol Metab (2005) 2.34
Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes (2003) 2.28
Weight changes following the initiation of new anti-hyperglycaemic therapies. Diabetes Obes Metab (2007) 2.19
Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab (2004) 2.16
The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord (1996) 2.13
Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab (2004) 1.97
Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest (1997) 1.95
Differential activation of ER stress and apoptosis in response to chronically elevated free fatty acids in pancreatic beta-cells. Am J Physiol Endocrinol Metab (2008) 1.68
Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis. J Hepatol (2007) 1.55
Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity (Silver Spring) (2006) 1.52
Effective diabetes care: a need for realistic targets. BMJ (2002) 1.43
Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice. Diabetes (2006) 1.39
Role of FoxO1 in FFA-induced oxidative stress in adipocytes. Am J Physiol Endocrinol Metab (2007) 1.26
Transgenic mice lacking white fat: models for understanding human lipoatrophic diabetes. Ann N Y Acad Sci (1999) 0.87
Gene expression variability in subcutaneous and omental adipose tissue of obese men. Gene Expr (2007) 0.82
Pathways to the analysis of microarray data. Trends Biotechnol (2005) 3.88
Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci U S A (2004) 3.67
Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective. Biochim Biophys Acta (2010) 3.19
Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans. Circulation (2013) 2.94
PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet (2007) 2.91
Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab (2008) 2.89
Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol (2006) 2.86
Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med (2010) 2.76
Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet (2011) 2.73
Adipogenesis and WNT signalling. Trends Endocrinol Metab (2008) 2.37
Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes (2003) 2.28
BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell (2012) 2.20
AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol Med (2008) 2.16
The obese healthy paradox: is inflammation the answer? Biochem J (2010) 2.14
Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis. J Clin Invest (2007) 2.03
Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis. BMC Syst Biol (2007) 2.01
Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes (2011) 1.91
Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol (2011) 1.89
The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform. Diabetes (2005) 1.76
Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med (2009) 1.72
CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. Cell Metab (2009) 1.68
IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes (2007) 1.56
Lipidomics: a new window to biomedical frontiers. Trends Biotechnol (2008) 1.52
ETO/MTG8 is an inhibitor of C/EBPbeta activity and a regulator of early adipogenesis. Mol Cell Biol (2004) 1.52
Using brown adipose tissue to treat obesity - the central issue. Trends Mol Med (2011) 1.51
Mitochondrial fusion is increased by the nuclear coactivator PGC-1beta. PLoS One (2008) 1.50
Deletion of the metabolic transcriptional coactivator PGC1β induces cardiac arrhythmia. Cardiovasc Res (2011) 1.46
Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese. Biochem Soc Trans (2008) 1.45
Wnt signalling and the control of cellular metabolism. Biochem J (2010) 1.42
Metabolomic approaches to phenotype characterization and applications to complex diseases. Expert Rev Mol Diagn (2006) 1.41
Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice. Diabetes (2006) 1.39
Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends Mol Med (2005) 1.37
Informatics and computational strategies for the study of lipids. Mol Biosyst (2007) 1.37
DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ Res (2010) 1.36
Digenic inheritance of severe insulin resistance in a human pedigree. Nat Genet (2002) 1.36
Beyond the sympathetic tone: the new brown fat activators. Cell Metab (2013) 1.32
PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy. Circ Res (2011) 1.31
Decreased brown adipocyte recruitment and thermogenic capacity in mice with impaired peroxisome proliferator-activated receptor (P465L PPARgamma) function. Endocrinology (2006) 1.29
Nicotine induces negative energy balance through hypothalamic AMP-activated protein kinase. Diabetes (2012) 1.28
Regional differences in the response of human pre-adipocytes to PPARgamma and RXRalpha agonists. Diabetes (2002) 1.27
Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free Radic Biol Med (2009) 1.26
Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45. Biochem Biophys Res Commun (2002) 1.26
A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr (2007) 1.26
Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis. J Biol Chem (2003) 1.25
Energization-dependent endogenous activation of proton conductance in skeletal muscle mitochondria. Biochem J (2008) 1.23
UCPs--unlikely calcium porters. Nat Cell Biol (2008) 1.17
Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. FASEB J (2010) 1.16
Obesity as a clinical and public health problem: is there a need for a new definition based on lipotoxicity effects? Biochim Biophys Acta (2010) 1.15
The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice. Free Radic Biol Med (2011) 1.10
Metabolic phenotyping of a model of adipocyte differentiation. Physiol Genomics (2009) 1.10
Below thermoneutrality, changes in activity do not drive changes in total daily energy expenditure between groups of mice. Cell Metab (2012) 1.10
Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1). Public Health Nutr (2007) 1.09
Stimulation of mitochondrial proton conductance by hydroxynonenal requires a high membrane potential. Biosci Rep (2008) 1.09
Bsx, a novel hypothalamic factor linking feeding with locomotor activity, is regulated by energy availability. Endocrinology (2008) 1.08
Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res (2005) 1.08
Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis. FASEB J (2005) 1.06
Pharmacological strategies for targeting BAT thermogenesis. Trends Pharmacol Sci (2013) 1.04
Hypothalamic fatty acid metabolism: a housekeeping pathway that regulates food intake. Bioessays (2007) 1.04
Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance. Diabetes (2010) 1.02
An allostatic control of membrane lipid composition by SREBP1. FEBS Lett (2010) 1.02
Assessment of brown adipose tissue function. Front Physiol (2013) 1.01
Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis. Diabetes (2012) 1.01
A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia (2013) 1.00
Visceral fat accumulation during lipid overfeeding is related to subcutaneous adipose tissue characteristics in healthy men. J Clin Endocrinol Metab (2013) 0.99
PPARs and adipocyte function. Mol Cell Endocrinol (2009) 0.98
Central resistin regulates hypothalamic and peripheral lipid metabolism in a nutritional-dependent fashion. Endocrinology (2008) 0.98
Origins of metabolic complications in obesity: ectopic fat accumulation. The importance of the qualitative aspect of lipotoxicity. Curr Opin Clin Nutr Metab Care (2011) 0.97
Signalling activity of beta-catenin targeted to different subcellular compartments. Biochem J (2004) 0.96
Leptin-mediated changes in hepatic mitochondrial metabolism, structure, and protein levels. Proc Natl Acad Sci U S A (2009) 0.95
Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome. Dis Model Mech (2009) 0.95
Hypothalamic AMP-activated protein kinase as a mediator of whole body energy balance. Rev Endocr Metab Disord (2011) 0.95
Genetic variants in human sterol regulatory element binding protein-1c in syndromes of severe insulin resistance and type 2 diabetes. Diabetes (2004) 0.94
NPs -- heart hormones that regulate brown fat? J Clin Invest (2012) 0.94
Defective peroxisomal proliferators activated receptor gamma activity due to dominant-negative mutation synergizes with hypertension to accelerate cardiac fibrosis in mice. Eur J Heart Fail (2009) 0.94
Ghrelin and lipid metabolism: key partners in energy balance. J Mol Endocrinol (2011) 0.92
Genome-wide profiling of microRNAs in adipose mesenchymal stem cell differentiation and mouse models of obesity. PLoS One (2011) 0.92
Current challenges in metabolomics for diabetes research: a vital functional genomic tool or just a ploy for gaining funding? Physiol Genomics (2008) 0.91
A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice. PLoS Med (2008) 0.91
Adipogenesis: new insights into brown adipose tissue differentiation. J Mol Endocrinol (2013) 0.90
Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity. Diabetes (2013) 0.89
Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat. Psychopharmacology (Berl) (2011) 0.89
Postprandial inflammatory response in adipose tissue of patients with metabolic syndrome after the intake of different dietary models. Mol Nutr Food Res (2011) 0.88
Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition. J Clin Endocrinol Metab (2008) 0.88
Thyroid hormones directly activate the expression of the human and mouse uncoupling protein-3 genes through a thyroid response element in the proximal promoter region. Biochem J (2005) 0.88
Peroxisome proliferator-activated receptor γ-dependent regulation of lipolytic nodes and metabolic flexibility. Mol Cell Biol (2012) 0.87
Psychosocial stress induces hyperphagia and exacerbates diet-induced insulin resistance and the manifestations of the Metabolic Syndrome. Psychoneuroendocrinology (2013) 0.87
Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats. Int J Neuropsychopharmacol (2011) 0.87
PGC-1α negatively regulates extrasynaptic NMDAR activity and excitotoxicity. J Neurosci (2012) 0.87
PGC-1beta: a co-activator that sets the tone for both basal and stress-stimulated mitochondrial activity. Adv Exp Med Biol (2009) 0.87
Brain lipogenesis and regulation of energy metabolism. Curr Opin Clin Nutr Metab Care (2008) 0.86
Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model. Dis Model Mech (2012) 0.86
A new role for lipocalin prostaglandin d synthase in the regulation of brown adipose tissue substrate utilization. Diabetes (2012) 0.83
[Adipose tissue as a therapeutic target in obesity]. Endocrinol Nutr (2009) 0.83
Gateway to the metabolic syndrome. Nat Med (2005) 0.83
Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation. PLoS One (2011) 0.83
Lipocalin prostaglandin D synthase and PPARγ2 coordinate to regulate carbohydrate and lipid metabolism in vivo. PLoS One (2012) 0.82
Ablation of Pparg2 impairs lipolysis and reveals murine strain differences in lipolytic responses. FASEB J (2012) 0.82
Lamin expression in human adipose cells in relation to anatomical site and differentiation state. J Clin Endocrinol Metab (2002) 0.82
Ablation of PGC1 beta prevents mTOR dependent endoplasmic reticulum stress response. Exp Neurol (2012) 0.82
Early peroxisome proliferator-activated receptor gamma regulated genes involved in expansion of pancreatic beta cell mass. BMC Med Genomics (2011) 0.81